LAG3 and non-small cell lung carcinoma: Subjects in cohort A were treatment-naïve NSCLC patients negative for driver genes, who had relatively entire immune functions and presented the mildest immune exhaustion status (lowest proportions of Treg cells, PD-1+ T cells and LAG-3+ T cells).